• Profile
Close

Identification of mycobacterial bacterioferritin B for immune screening of tuberculosis and latent tuberculosis infection

Tuberculosis Aug 26, 2017

Yang X et al. – The study aimed at identifying novel mycobacterial antigens that would improve the sensitivity and specificity for tuberculosis (TB) diagnosis and screening of latent TB infection (LTBI). In this study, higher BfrB (bacterioferritin B)–specific IFN–γ responses were observed for PTB (Pulmonary TB) and LTBI groups compared to HCs (Healthy Controls). BfrB has potential to increase the sensitivity for LTBI screening as BfrB–specific cellular immune responses were comparable to ESAT–6/CFP–10 responses in patients with LTBI. In addition, strong BfrB–specific IFN–? release in a healthy cohort could be cautionary to identify leaky LTBI from HCs.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay